PLASMACYTOMA OF BONE

Clinical trials for PLASMACYTOMA OF BONE explained in plain language.

Never miss a new study

Get alerted when new PLASMACYTOMA OF BONE trials appear

Sign up with your email to follow new studies for PLASMACYTOMA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New combo therapy targets rare bone cancer with immune-boosting drug

Disease control Recruiting now

This study tests whether combining radiation with a bispecific antibody (CM336) can safely treat solitary bone plasmacytoma that has mild bone marrow involvement. About 21 adults with this rare plasma cell disorder will receive the combination therapy. The goal is to control the …

Matched conditions: PLASMACYTOMA OF BONE

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 14, 2026 12:01 UTC

PLASMACYTOMA OF BONE

Get alerted when new PLASMACYTOMA OF BONE trials appear

New combo therapy targets rare bone cancer with immune-boosting drug